Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: Implications on immunogenicity and immunodominance

被引:58
作者
Vitiello, A
Sette, A
Yuan, L
Farness, P
Southwood, S
Sidney, J
Chesnut, RW
Grey, HM
Livingston, B
机构
[1] CYTEL CORP,SAN DIEGO,CA 92121
[2] LA JOLLA INST ALLERGY & IMMUNOL,LA JOLLA,CA
关键词
immunogenicity; immunodominance; cytotoxic T lymphocyte; peptide vaccine; cDNA priming;
D O I
10.1002/eji.1830270315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the mechanisms that influence the immunogenicity and immunodominance of potential cytotoxic T lymphocyte (CTL) epitopes, we conducted a systematic analysis of the CTL response raised in HLA-A*0201/K-b (A2/K-b) transgenic mice against the viral antigen, hepatitis B virus polymerase (HBV pol). From a pool of 26 nonamer peptides containing the HLA-A*0201-binding motif, we selected A2-binding peptides, immunized A2/K-b animals, and tested the CTL raised against the peptide for recognition of HBV pol transfectants. Of nine immunogenic CTL epitopes, only four were recognized on HBV pol transfectants, whereas the other five were cryptic. Characterization of the peptide-specific CTL lines indicated that crypticity may result from either poor processing or low T cell receptor (TCR) avidity. To identify the immunodominant epitopes, we determined the CTL specificities induced in A2/K-b animals in response to priming with HBV pol cDNA. We obtained a response against three epitopes that were contained with the set of four epitopes recognized by peptide-specific CTL on HBV pol transfectants. Comparative analysis of cDNA priming and peptide priming revealed, therefore, the presence of a subdominant epitope. We conclude that for the HBV pol antigen, the repertoire of CTL specificities is shaped by major histocompatibility complex class I peptide binding capacity, antigen processing, and TCR availability.
引用
收藏
页码:671 / 678
页数:8
相关论文
共 35 条
[1]   HISTOCOMPATIBILITY-LINKED IMMUNE-RESPONSE GENES [J].
BENACERR.B ;
MCDEVITT, HO .
SCIENCE, 1972, 175 (4019) :273-&
[2]   MURINE CYTO-TOXIC LYMPHOCYTE-T RECOGNITION OF INDIVIDUAL INFLUENZA-VIRUS PROTEINS - HIGH-FREQUENCY OF NONRESPONDER MHC CLASS-I ALLELES [J].
BENNINK, JR ;
YEWDELL, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) :1935-1939
[3]   ANTIGEN PRESENTATION TO CYTOTOXIC T-LYMPHOCYTES IN-VIVO [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :639-641
[4]   DETERMINANT SELECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGENIC PEPTIDES IS EXPLAINED BY CLASS I-PEPTIDE AFFINITY AND IS STRONGLY INFLUENCED BY NONDOMINANT ANCHOR RESIDUES [J].
CHEN, WS ;
KHILKO, S ;
FECONDO, J ;
MARGULIES, DH ;
MCCLUSKEY, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1471-1483
[5]   IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J].
COX, AL ;
SKIPPER, J ;
CHEN, Y ;
HENDERSON, RA ;
DARROW, TL ;
SHABANOWITZ, J ;
ENGELHARD, VH ;
HUNT, DF ;
SLINGLUFF, CL .
SCIENCE, 1994, 264 (5159) :716-719
[6]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[7]   EFFICIENT PROCESSING OF AN ANTIGENIC SEQUENCE FOR PRESENTATION BY MHC CLASS-I MOLECULES DEPENDS ON ITS NEIGHBORING RESIDUES IN THE PROTEIN [J].
DELVAL, M ;
SCHLICHT, HJ ;
RUPPERT, T ;
REDDEHASE, MJ ;
KOSZINOWSKI, UH .
CELL, 1991, 66 (06) :1145-1153
[8]   SPECIFICITY OF ANTIGEN PROCESSING FOR MHC CLASS-I RESTRICTED PRESENTATION IS CONSERVED BETWEEN MOUSE AND MAN [J].
FALK, K ;
ROTZSCHKE, O ;
RAMMENSEE, HG .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (05) :1323-1326
[9]   ALLELE-SPECIFIC MOTIFS REVEALED BY SEQUENCING OF SELF-PEPTIDES ELUTED FROM MHC MOLECULES [J].
FALK, K ;
ROTZSCHKE, O ;
STEVANOVIC, S ;
JUNG, G ;
RAMMENSEE, HG .
NATURE, 1991, 351 (6324) :290-296
[10]   HEPATITIS-B VIRUS (HBV)-SPECIFIC CYTOTOXIC T-CELL RESPONSE IN HUMANS - PRODUCTION OF TARGET-CELLS BY STABLE EXPRESSION OF HBV-ENCODED PROTEINS IN IMMORTALIZED HUMAN B-CELL LINES [J].
GUILHOT, S ;
FOWLER, P ;
PORTILLO, G ;
MARGOLSKEE, RF ;
FERRARI, C ;
BERTOLETTI, A ;
CHISARI, FV .
JOURNAL OF VIROLOGY, 1992, 66 (05) :2670-2678